Sumitomo Mitsui Trust Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-516,629
| Closed | -$38.6M | – | 1217 |
|
|
2021
Q1 | $38.6M | Buy |
516,629
+78,430
| +18% | +$5.87M | 0.02% | 608 |
|
|
2020
Q4 | $47.5M | Buy |
438,199
+19,964
| +5% | +$2.17M | 0.03% | 553 |
|
|
2020
Q3 | $37M | Sell |
418,235
-54,242
| -11% | -$4.79M | 0.02% | 574 |
|
|
2020
Q2 | $50.4M | Sell |
472,477
-20,044
| -4% | -$2.14M | 0.04% | 494 |
|
|
2020
Q1 | $29.2M | Sell |
492,521
-4,945
| -1% | -$293K | 0.03% | 568 |
|
|
2019
Q4 | $34.4M | Buy |
497,466
+34,089
| +7% | +$2.36M | 0.03% | 585 |
|
|
2019
Q3 | $48.1M | Buy |
463,377
+304,472
| +192% | +$31.6M | 0.04% | 459 |
|
|
2019
Q2 | $14.7M | Buy |
158,905
+90,457
| +132% | +$8.38M | 0.01% | 697 |
|
|
2019
Q1 | $6.26M | Buy |
+68,448
| New | +$6.26M | 0.01% | 708 |
|